Published in Mol Cancer on December 19, 2016
CMTM5 inhibits renal cancer cell growth through inducing cell-cycle arrest and apoptosis. Oncol Lett (2017) 0.75
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade. Oncotarget (2017) 0.75
miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5. Oncotarget (2017) 0.75
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (1999) 23.45
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature (2010) 14.50
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer (2006) 11.49
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst (1991) 9.39
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol (2005) 6.44
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell (2007) 6.06
High drug attrition rates--where are we going wrong? Nat Rev Clin Oncol (2011) 5.67
BAP1 loss defines a new class of renal cell carcinoma. Nat Genet (2012) 4.97
'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res (1966) 4.89
Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J (2002) 4.83
Tumour suppression by the human von Hippel-Lindau gene product. Nat Med (1995) 4.71
Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun (2013) 4.35
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02
The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol (1991) 3.95
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol (2013) 3.68
HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int (1994) 3.60
Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene. Cancer Discov (2011) 3.45
HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods (2005) 3.41
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer (2010) 3.33
Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene (1999) 3.01
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res (2006) 2.65
Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res (1992) 2.62
The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques (2007) 2.58
Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc (2007) 2.54
Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol (1997) 2.54
Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res (1986) 2.30
Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol Cell Proteomics (2008) 2.29
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res (2013) 2.27
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res (2006) 2.24
Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol (2014) 2.19
Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res (1984) 2.13
Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene (2008) 2.12
Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res (1996) 2.10
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet (2010) 2.06
Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. Cancer Res (2010) 2.03
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res (2008) 2.01
Breast cancer cell lines: friend or foe? Breast Cancer Res (2003) 1.98
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2014) 1.93
Variable cultural acquisition costs constrain cumulative cultural evolution. PLoS One (2011) 1.90
Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J (2008) 1.88
Influence of the RNA-binding protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Mol Cell Biol (2003) 1.83
Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int (1984) 1.76
Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest (2008) 1.76
BAY 43-9006: preclinical data. Curr Pharm Des (2002) 1.76
Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci (2009) 1.74
Type-specific cell line models for type-specific ovarian cancer research. PLoS One (2013) 1.73
Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res (2003) 1.67
Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res (2007) 1.66
Activation of the mTOR signaling pathway in renal clear cell carcinoma. J Urol (2007) 1.66
SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. Oncogene (2015) 1.65
Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta (2009) 1.62
Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res (1990) 1.53
Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res (1992) 1.52
Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer (2006) 1.51
Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha. Carcinogenesis (2006) 1.49
Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem Pharmacol (2013) 1.47
hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol (2008) 1.40
Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis (1999) 1.38
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Res (2007) 1.36
Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. Mol Cancer Res (2011) 1.33
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. Ann Oncol (2012) 1.33
3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev (2014) 1.30
Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells. Cancer Lett (2010) 1.28
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration. Proc Natl Acad Sci U S A (2011) 1.28
Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res (2007) 1.27
Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27
Translational medicine: Cancer lessons from mice to humans. Nature (2011) 1.26
Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer (1991) 1.26
Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer (2013) 1.20
Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br J Cancer (2009) 1.20
Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Oncotarget (2014) 1.20
Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clin Epigenetics (2015) 1.19
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer. Cancer Cell (2013) 1.15
Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene (2000) 1.13
Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms. Am J Physiol Renal Physiol (2006) 1.12
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line. PLoS One (2013) 1.11
Guidelines for the use of cell lines in biomedical research. Br J Cancer (2014) 1.11
Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53. Int J Cancer (1996) 1.10
HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res (2012) 1.09
PBRM1 and BAP1 as novel targets for renal cell carcinoma. Cancer J (2013) 1.07
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci U S A (2011) 1.05
Metastasis of human tumors in athymic nude mice. Int J Cancer (1979) 1.05
Human renal carcinoma: characterization of five new cell lines. J Surg Oncol (1985) 1.05
Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma. J Cancer Res Clin Oncol (2002) 1.02
A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Cancer Genet Cytogenet (2005) 1.02
p53 regulation and function in renal cell carcinoma. Cancer Res (2005) 1.01
TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Mol Cancer Res (2012) 1.01
P53 mutations and other prognostic factors of renal cell carcinoma. Urol Int (2001) 1.01
Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P. PLoS One (2013) 1.00
p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets? Cancer (2010) 1.00
Establishment and characterization of five new human renal tumor xenografts. Am J Pathol (1992) 0.99
Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res (2003) 0.98
Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma. Clin Epigenetics (2013) 0.98
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis. Stem Cell Rev (2015) 0.84
Functional significance of CD105-positive cells in papillary renal cell carcinoma. BMC Cancer (2017) 0.77
Insulin-like growth factor-1 signaling in renal cell carcinoma. BMC Cancer (2016) 0.75